糖尿病痛性神经病变合并格林巴利1例并文献复习
A Case of Diabetic Neuropathic Pain with Guillain-Barré Syndrome and a Literature Review
DOI: 10.12677/acm.2025.151260, PDF,   
作者: 曾 睿:青岛大学青岛医学院,山东 青岛;邓玉杰, 赵宇航, 李成乾*:青岛大学附属医院内分泌与代谢性疾病科,山东 青岛
关键词: 糖尿病格林–巴利综合征糖尿病痛性神经病变Diabetes Mellitus Guillain-Barré Syndrome Diabetic Painful Neuropathy
摘要: 糖尿病痛性神经病变(PDN)是临床上常见的一类感觉性周围神经病变。在众多致病因素中,远端对称性多发性神经病变(DSPN)占据主导地位。而格林巴利综合征则是一种急性炎症性周围神经病,又称慢性炎症性脱髓鞘性多发神经根神经病(CIDP),是一种免疫介导的脱髓鞘性周围神经病。当糖尿病痛性神经病变与格林巴利综合征合并时,病情通常会变得更为复杂。首先,这两种疾病存在密切关联及潜在的共同病理生理机制。研究显示,在其发病进程中,免疫系统可能发挥着至关重要的作用。由于这两种疾病所表现出的症状可能会相互交织、彼此重叠,因此很容易造成误诊和漏诊的情况发生。明确它们各自独特的临床表现、神经电生理特点以及实验室检查指标的变化,有助于提高诊断的准确性。总之,对糖尿病痛性神经病变并发格林巴利的探讨不仅能加强我们对神经病变的理解,也能为病人提供更精确、更有成效的医疗策略,从而提升他们的生活品质。本研究通过综合文献综述,深入探讨了格林巴利综合征与糖尿病痛性神经病变的发病机制、临床表现、实验室检查方法及治疗方案,旨在促进这两种疾病的及早诊断与有效治疗。
Abstract: Diabetic painful neuropathy (PDN) is a common clinical class of sensory peripheral neuropathy. Among the many causative factors, distal symmetrical polyneuropathy (DSPN) dominates. The prevalence of PDN in the diabetic patient population is estimated to be as high as 16%, and 39% of patients in this group fail to receive timely and effective therapeutic measures. Whereas, Guillain-Barré syndrome is an acute inflammatory peripheral neuropathy, also known as chronic inflammatory demyelinating polyradiculoneuropathy (CIDP), which is an immune-mediated demyelinating peripheral neuropathy. When diabetic painful neuropathy is combined with Guillain-Barré syndrome, the condition usually becomes more complex. First, there is a close association and potential common pathophysiologic mechanisms between these two diseases. Studies have shown that the immune system may play a crucial role in their pathogenesis. As the symptoms of these two diseases may be intertwined and overlap with each other, they can be easily misdiagnosed and underdiagnosed. Clarifying their unique clinical manifestations, neurophysiologic features, and changes in laboratory tests can help improve the accuracy of diagnosis. In conclusion, the exploration of diabetic painful neuropathy complicating Guillain-Barré will not only enhance our understanding of neuropathy, but also provide patients with more precise and productive medical strategies, thus improving their quality of life. In this study, through a comprehensive literature review, the pathogenesis, clinical manifestations, laboratory methods, and treatment options of Guillain-Barré syndrome and diabetic painful neuropathy were discussed in depth, aiming to promote early diagnosis and effective treatment of these two diseases.
文章引用:曾睿, 邓玉杰, 赵宇航, 李成乾. 糖尿病痛性神经病变合并格林巴利1例并文献复习[J]. 临床医学进展, 2025, 15(1): 1955-1962. https://doi.org/10.12677/acm.2025.151260

参考文献

[1] Boulton, A.J.M., Malik, R.A., Arezzo, J.C. and Sosenko, J.M. (2004) Diabetic Somatic Neuropathies. Diabetes Care, 27, 1458-1486. [Google Scholar] [CrossRef] [PubMed]
[2] Boulton, A.J.M., Vinik, A.I., Arezzo, J.C., Bril, V., Feldman, E.L., Freeman, R., et al. (2005) Diabetic Neuropathies: A Statement by the American Diabetes Association. Diabetes Care, 28, 956-962. [Google Scholar] [CrossRef] [PubMed]
[3] Cernea, S. and Raz, I. (2021) Management of Diabetic Neuropathy. Metabolism, 123, Article 154867. [Google Scholar] [CrossRef] [PubMed]
[4] Treede, R.-., Jensen, T.S., Campbell, J.N., Cruccu, G., Dostrovsky, J.O., Griffin, J.W., et al. (2008) Neuropathic Pain: Redefinition and a Grading System for Clinical and Research Purposes. Neurology, 70, 1630-1635. [Google Scholar] [CrossRef] [PubMed]
[5] 中华医学会神经病学分会, 中华医学会神经病学分会周围神经病协作组. 中国吉兰-巴雷综合征诊治指南2024 [J]. 中华神经科杂志, 2024, 57(9): 936-944.
[6] Suri, V., Pandey, S., Singh, J. and Jena, A. (2021) Acute-Onset Chronic Inflammatory Demyelinating Polyneuropathy after COVID-19 Infection and Subsequent Chadox1 Ncov-19 Vaccination. BMJ Case Reports, 14, e245816. [Google Scholar] [CrossRef] [PubMed]
[7] Shahrizaila, N., Lehmann, H.C. and Kuwabara, S. (2021) Guillain-Barré Syndrome. The Lancet, 397, 1214-1228. [Google Scholar] [CrossRef] [PubMed]
[8] Tesfaye, S., Chaturvedi, N., Eaton, S.E.M., Ward, J.D., Manes, C., Ionescu-Tirgoviste, C., et al. (2005) Vascular Risk Factors and Diabetic Neuropathy. New England Journal of Medicine, 352, 341-350. [Google Scholar] [CrossRef] [PubMed]
[9] Dima, A., Dumitrescu, L., Berza, I., et al. (2016) Acute Bilateral Phrenic Neuropathy: From Diabetes Mellitus to Focal Guillain-Barré Syndrome. Maedica, 11, 61-63.
[10] Freeman, R., Durso-DeCruz, E. and Emir, B. (2008) Efficacy, Safety, and Tolerability of Pregabalin Treatment for Painful Diabetic Peripheral Neuropathy: Findings from Seven Randomized, Controlled Trials across a Range of Doses. Diabetes Care, 31, 1448-1454. [Google Scholar] [CrossRef] [PubMed]
[11] Alshekhlee, A., Hussain, Z., Sultan, B. and Katirji, B. (2008) Guillain-Barré Syndrome: Incidence and Mortality Rates in US Hospitals. Neurology, 70, 1608-1613. [Google Scholar] [CrossRef] [PubMed]
[12] Bae, J.S., Kim, Y.J. and Kim, J.K. (2015) Diabetes Mellitus Exacerbates the Clinical and Electrophysiological Features of Guillain-Barré Syndrome. European Journal of Neurology, 23, 439-446. [Google Scholar] [CrossRef] [PubMed]
[13] Madonna, R., Balistreri, C.R., Geng, Y. and De Caterina, R. (2017) Diabetic Microangiopathy: Pathogenetic Insights and Novel Therapeutic Approaches. Vascular Pharmacology, 90, 1-7. [Google Scholar] [CrossRef] [PubMed]
[14] Tesfaye, S., Boulton, A.J.M., Dyck, P.J., Freeman, R., Horowitz, M., Kempler, P., et al. (2010) Diabetic Neuropathies: Update on Definitions, Diagnostic Criteria, Estimation of Severity, and Treatments. Diabetes Care, 33, 2285-2293. [Google Scholar] [CrossRef] [PubMed]
[15] Kuwabara, S., Tsuneyama, A. and Misawa, S. (2020) Chronic Inflammatory Demyelinating Polyneuropathy and Diabetes. Journal of Neurology, Neurosurgery & Psychiatry, 91, 1035-1036. [Google Scholar] [CrossRef] [PubMed]
[16] 陈芳媛, 邹秀兰, 杨建明, 等. 胰岛素自身免疫综合征一例[J]. 中华全科医师杂志, 2014, 13(10): 876-877.
[17] Xu, Q., Ni, J., Han, B., Yan, S., Wei, X., Feng, G., et al. (2022) Causal Relationship between Gut Microbiota and Autoimmune Diseases: A Two-Sample Mendelian Randomization Study. Frontiers in Immunology, 12, Article 746998. [Google Scholar] [CrossRef] [PubMed]
[18] Cao, F., Zhang, H., Xu, B. and Li, C. (2024) Genetic Association between Gut Microbiota and the Risk of Guillain-Barré Syndrome. Journal of Affective Disorders, 357, 171-178. [Google Scholar] [CrossRef] [PubMed]
[19] Peric, S., Bozovic, I., Bjelica, B., Berisavac, I., Stojiljkovic, O., Basta, I., et al. (2017) Diabetes Mellitus May Affect Short‐Term Outcome of Guillain‐Barré Syndrome. Journal of the Peripheral Nervous System, 22, 127-130. [Google Scholar] [CrossRef] [PubMed]